INBX vs WDAY · rev $1.3M vs P/E 135, rev $5.19B
Inhibrx Biosciences, Inc. (INBX) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
INBX currently screens at market cap $1.28B. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the INBX and WDAY stock pages for the full models.
Not investment advice.